Polar Asset Management Partners’s Peak Bio, Inc. Common Stock PKBO Stock Holding History

Polar Asset Management Partners’s Portfolio PKBO Stock Details PKBO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-75,000	Closed	-$748K	–	1377
2022 Q3	$748K	Hold	75,000	–	–	0.01%	795
2022 Q2	$740K	Hold	75,000	–	–	0.01%	780
2022 Q1	$738K	Hold	75,000	–	–	0.01%	699
2021 Q4	$730K	Hold	75,000	–	–	0.01%	799
2021 Q3	$734K	Hold	75,000	–	–	0.01%	761
2021 Q2	$726K	Hold	75,000	–	–	0.01%	707
2021 Q1	$724K	Buy	+75,000	New	+$728K	0.01%	554

Other funds holding PKBO

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Polar Asset Management Partners's PKBO Position: Q4 2022 in Review

Polar Asset Management Partners sold out of Peak Bio, Inc. Common Stock (PKBO) in Q4 2022, closing a stake of 75,000 shares — an estimated $748K sold.

Polar Asset Management Partners first reported a position in PKBO in Q1 2021 and held it in 7 quarters. The position peaked at $748K in Q3 2022. 9 funds tracked by Wall St. Rank hold PKBO as of Q4 2022.

Polar Asset Management Partners reported no remaining Peak Bio, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Polar Asset Management Partners sold 75,000 Peak Bio, Inc. Common Stock shares in Q4 2022, an estimated $748K.
Polar Asset Management Partners first reported a position in Peak Bio, Inc. Common Stock in Q1 2021 and held it in 7 quarters.
Polar Asset Management Partners's Peak Bio, Inc. Common Stock position peaked at $748K in Q3 2022.
9 funds tracked by Wall St. Rank held Peak Bio, Inc. Common Stock as of Q4 2022.

Based on Polar Asset Management Partners's 13F filing for Q4 2022, filed 14 Feb 2023.